Caption Management, LLC Tricida, Inc. Transaction History

Caption Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.14 - $12.49 $6,533 - $582,908	-46,670 Reduced 31.82%	100,000 $15,000
Q3 2022 Nov 14, 2022	BUY	$8.51 - $13.6 $141,861 - $226,712	16,670 Added 12.82%	146,670 $1.54 Million
Q2 2022 Aug 15, 2022	BUY	$7.31 - $11.85 $950,300 - $1.54 Million	130,000 New	130,000 $1.26 Million

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.